Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Total Debt (2022 - 2026)

HeartSciences (HSCS) has disclosed Total Debt for 3 consecutive years, with $49470.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Total Debt changed N/A year-over-year to $49470.0, compared with a TTM value of $49470.0 through Oct 2024, changed N/A, and an annual FY2023 reading of $500000.0, down 88.74% over the prior year.
  • Total Debt was $49470.0 for Q4 2024 at HeartSciences, down from $500000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $4.4 million in Q2 2022 and bottomed at $49470.0 in Q4 2024.
  • Average Total Debt over 3 years is $1.1 million, with a median of $500000.0 recorded in 2023.
  • The sharpest move saw Total Debt crashed 88.74% in 2023, then changed 0.0% in 2024.
  • Year by year, Total Debt stood at $1.0 million in 2022, then crashed by 50.0% to $500000.0 in 2023, then plummeted by 90.11% to $49470.0 in 2024.
  • Business Quant data shows Total Debt for HSCS at $49470.0 in Q4 2024, $500000.0 in Q3 2024, and $500000.0 in Q3 2023.